Viridian Therapeutics
VRDN
#5299
Rank
โ‚ฌ0.96 B
Marketcap
11,87ย โ‚ฌ
Share price
-0.44%
Change (1 day)
-1.33%
Change (1 year)

EPS for Viridian Therapeutics (VRDN)

EPS in 2023 (TTM): -4,57ย โ‚ฌ

According to Viridian Therapeutics's latest financial reports the company's current EPS (TTM) is -4,28ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -3,54ย โ‚ฌ an increase over its 2021 EPS that were of -6,67ย โ‚ฌ.

EPS history for Viridian Therapeutics from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-4,57ย โ‚ฌ29.02%
2022-3,54ย โ‚ฌ-46.83%
2021-6,67ย โ‚ฌ-73.94%
2020-25,59ย โ‚ฌ44.73%
2019-17,68ย โ‚ฌ22.94%
2018-14,38ย โ‚ฌ-27.33%
2017-19,79ย โ‚ฌ-91.47%
2016-231,95ย โ‚ฌ-19.17%
2015-286,97ย โ‚ฌ-75.48%
2014-1.170ย โ‚ฌ582.47%
2013-171,49ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-1,92ย โ‚ฌ-55.24%๐Ÿ‡บ๐Ÿ‡ธ USA